BluDental Clinique Holding SA welcomes SARUDA SA Holding as a new shareholder

LUXEMBOURG CITY, Luxembourg & ZUG, Switzerland - Feb. 23, 2016 - PRLog -- Bludental Clinique Holding SA, Luxembourg City, Luxembourg, welcomes SRD SARUDA Investments SA, Zug, Switzerland as its new shareholder.

Bludental Clinique Holding SA (BDCH), one of the largest, fast-growing providers of affordable dental healthcare to Italian public, signed today an agreement of minority shareholder entry with SRD Saruda Investments SA (SARUDA) from Switzerland.

SARUDA has acquired a 49% stake in Bludental Clinique Holding, which operates through its Italian operation Bludental Clinique Italia srl, holding sole or majority stakes in a large number of dental clinics across the country.

The entry of SARUDA shall create a value for both its shareholders and its customers (patients) by providing additional expertize and knowledge in fast commercialization of the concept.

The Bludental Group has registered more than 100.000 customers till today, and aims to growth in a number of dental clinics in and outside of Italy to over 100 within the next 2-3 years.

Bludental Clinique brand was created by Mr. Fabio Valleriani in 2009 with the goal to provide an affordable, high quality dental care to Italian public.

The group operates dental clinics especially in centre of the Italian peninsula. It is perceived a pioneer in cost-efficient and high patient value dental treatments.

SARUDA was founded around Dr. Sante Giovanni Albonetti, a MedTech veteran with around 40 years of medical technologies experience, Daniel J. Novacek, a MedTech international executive, and Ruth Ch. Gessner, a fmr. global VP, and currently a CEO of puracon GmbH, both with long-term tenures at world wide largest dental technologies companies as Dentsply International, NobelBiocare, and Danaher Corp. / KAVO.

SARUDA is an investor in diversity of growth stage MedTech companies in a multiple of medical disciplines.

Fabio Valleriani will assume a role of the Group’s CEO. Dr. Sante Giovanni Albonetti will assume a role of COO and CFO, and Daniel J. Novacek of Head of Corporate Strategy, Business Development and Chief Communication Officer.

Fabio Valleriani stated: “We are very excited to have the opportunity to welcome a group of highly experienced, passionate and dedicated MedTech professionals. Their input will certainly add a great value to our project to become one of the largest and most respected providers of affordable dental care to general public in a multiple of European jurisdictions. SARUDA will enter a group of highly competent dental professionals around the core team, which laid out the foundation for further growth of the project.”

Dr. Sante Giovanni Albonetti stated: “It is our privilege to join a group of successful entrepreneurs around Fabio. We are delighted about the opportunity to deploy our unique skills end expertize within the industry, and to give our full contribution to the project.”

For further information, please contact:

Daniel J. Novacek at +49-160-96776691 or

Daniel J. Novacek
Tags:Dental, Healthcare, Medtech, Investment, Private Equity, Lifescience, Medical Services
Industry:Banking, Health, Investment, Medical, Technology
Location:Luxembourg City - Luxembourg - Luxembourg
Zug - Zug - Switzerland
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Feb 25, 2016

Like PRLog?
Click to Share